HBK Sorce Advisory LLC Sells 175 Shares of Danaher Corporation (NYSE:DHR)

HBK Sorce Advisory LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,891 shares of the conglomerate’s stock after selling 175 shares during the period. HBK Sorce Advisory LLC’s holdings in Danaher were worth $593,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DHR. LaFleur & Godfrey LLC boosted its position in shares of Danaher by 1.5% in the 4th quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate’s stock worth $6,853,000 after purchasing an additional 440 shares in the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock worth $44,241,000 after acquiring an additional 35,730 shares in the last quarter. IFP Advisors Inc grew its stake in shares of Danaher by 2.9% in the fourth quarter. IFP Advisors Inc now owns 6,951 shares of the conglomerate’s stock worth $1,595,000 after acquiring an additional 197 shares during the last quarter. Lake Street Advisors Group LLC increased its holdings in shares of Danaher by 1.2% during the fourth quarter. Lake Street Advisors Group LLC now owns 5,967 shares of the conglomerate’s stock valued at $1,371,000 after acquiring an additional 71 shares in the last quarter. Finally, Whipplewood Advisors LLC purchased a new position in shares of Danaher in the 4th quarter worth about $198,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DHR. Argus reduced their price objective on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Bank of America lowered their price objective on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. HSBC cut their target price on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Finally, Jefferies Financial Group decreased their price target on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $248.61.

Danaher Price Performance

Shares of NYSE:DHR opened at $201.88 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $144.48 billion, a PE ratio of 39.20, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. The firm’s 50 day moving average price is $194.61 and its 200-day moving average price is $208.77. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.